Presentation EuroPCR 2026 Three-year outcomes of the SMART trial Presenter: Howard Herrmann May 20, 2026 REGISTER for free or LOG IN to view this content Aortic Valve Stroke Heart Failure Hemodynamics Echo Presentation EuroPCR 2026 Up Next Presentation EuroPCR 2026 Cryotherapy for vulnerable plaque: a first-in-human study Presenter: Carlos Collet May 20, 2026 More slides + Presentation EuroPCR 2026 Two-year outcomes of contemporary TAVI valves: LANDMARK, a randomised, non-inferiority trial Presenter: Patrick Serruys May 20, 2026 Presentation EuroPCR 2026 Outcomes after TAVI with latest-generation intra- and supra-annular self-expanding valves Presenter: Matteo Casenghi May 20, 2026 We Recommend
Presentation EuroPCR 2026 Cryotherapy for vulnerable plaque: a first-in-human study Presenter: Carlos Collet May 20, 2026
Presentation EuroPCR 2026 Two-year outcomes of contemporary TAVI valves: LANDMARK, a randomised, non-inferiority trial Presenter: Patrick Serruys May 20, 2026
Presentation EuroPCR 2026 Outcomes after TAVI with latest-generation intra- and supra-annular self-expanding valves Presenter: Matteo Casenghi May 20, 2026